These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21633658)

  • 21. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond.
    Lin HY; Yang YL; Wang PW; Wang FS; Huang YH
    Cells; 2020 Apr; 9(4):. PubMed ID: 32331364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular or Exosomal microRNAs Associated with CCN Gene Expression in Liver Fibrosis.
    Chen L; Brigstock DR
    Methods Mol Biol; 2017; 1489():465-480. PubMed ID: 27734397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nrf2: a potential target for new therapeutics in liver disease.
    Bataille AM; Manautou JE
    Clin Pharmacol Ther; 2012 Sep; 92(3):340-8. PubMed ID: 22871994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic stellate cells and innate immunity in alcoholic liver disease.
    Suh YG; Jeong WI
    World J Gastroenterol; 2011 May; 17(20):2543-51. PubMed ID: 21633659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    Zhang CY; Yuan WG; He P; Lei JH; Wang CX
    World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease progression in NASH: new paradigms.
    Bohinc BN; Diehl AM
    Clin Liver Dis; 2012 Aug; 16(3):549-65. PubMed ID: 22824480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor.
    Bhushan B; Michalopoulos GK
    Chem Biol Interact; 2020 Jun; 324():109090. PubMed ID: 32283070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of microRNAs in the different phases of liver regeneration.
    Kern AE; Ortmayr G; Assinger A; Starlinger P
    Expert Rev Gastroenterol Hepatol; 2023; 17(10):959-973. PubMed ID: 37811642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
    Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
    J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis.
    Caviglia JM; Yan J; Jang MK; Gwak GY; Affo S; Yu L; Olinga P; Friedman RA; Chen X; Schwabe RF
    Hepatology; 2018 Jun; 67(6):2414-2429. PubMed ID: 29091291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic venography and wedge hepatic vein pressure measurements in diffuse liver disease.
    Cavaluzzi JA; Sheff R; Harrington DP; Kaufman SL; Barth K; Maddrey WC; White RI
    AJR Am J Roentgenol; 1977 Sep; 129(3):441-6. PubMed ID: 409197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair.
    Kitto LJ; Henderson NC
    Hepatol Commun; 2021 Mar; 5(3):358-370. PubMed ID: 33681672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid signaling and liver therapeutics.
    Mallat A; Teixeira-Clerc F; Lotersztajn S
    J Hepatol; 2013 Oct; 59(4):891-6. PubMed ID: 23567085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
    Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
    Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of miR‑155 in physiological and pathological processes of liver injury (Review).
    Feng X; Bao J; Song C; Xie L; Tan X; Li J; Jia H; Tian M; Qi J; Qin C; Bian H
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acids and hepatic stellate cells in liver disease.
    Lee YS; Jeong WI
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():75-9. PubMed ID: 22320921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury.
    Markovic J; Sharma AD; Balakrishnan A
    Cells; 2020 Jul; 9(8):. PubMed ID: 32717951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.